Albatroz Therapeutics
  • Home
  • Science
  • About
  • News
Albatroz Therapeutics is a pre-clinical stage biotechnology company with a mission to treat solid tumors and arthritic disorders that depend on extracellular matrix (ECM) remodeling.

TEAM

Frederic Bard
Frederic Bard
​CEO & Scientific Founder​
Guy Heathers
Guy Heathers
CBO & Business Co-Founder
Cheng-I Wang
Cheng-I Wang
​Head of Antibody Development
​
Picture
Florian Schuster
​Investor & Advisor
Picture
Kristina Rutkute
Director, Business Development
© Albatroz Therapeutics Pte. Ltd.
21 Biopolis Rd, #02-03 Nucleos North Tower, Singapore 138567


Terms of Use
  • Home
  • Science
  • About
  • News